KR20030044042A - 감광성 활성성분을 함유하는 경피 치료 시스템 - Google Patents
감광성 활성성분을 함유하는 경피 치료 시스템 Download PDFInfo
- Publication number
- KR20030044042A KR20030044042A KR10-2003-7005782A KR20037005782A KR20030044042A KR 20030044042 A KR20030044042 A KR 20030044042A KR 20037005782 A KR20037005782 A KR 20037005782A KR 20030044042 A KR20030044042 A KR 20030044042A
- Authority
- KR
- South Korea
- Prior art keywords
- transdermal therapeutic
- tts
- therapeutic system
- active ingredient
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (11)
- 활성성분(들)을 함유하는 중합체 매트릭스와 지지층(backing layer)으로 되는 구조이고, 적어도 하나의 감광성 활성성분을 함유하는 경피 치료 시스템(TTS)으로서,상기 TTS가, UV 영역에서 광을 흡수하고, 그자체로는 약리 작용을 갖지 않고, TTS의 중합체 매트릭스에 분산 또는 용해되고, 및/또는 TTS의 지지층에 균일하게 분포되는 적어도 하나의 무색 성분을 함유함을 특징으로 하는 경피 치료 시스템.
- 제1항에 있어서,지지층으로서, 폴리에스테르, 폴리에틸렌, 폴리프로필렌, 폴리우레탄, 에틸렌비닐아세테이트, 또는 상기 중합체들의 혼합물로 되는 투명 필름을 바람직하게 사용함에 의해 투명 지지층을 구비함을 특징으로 하는 경피 치료 시스템.
- 제1항 또는 제2항에 있어서,지지층이 무색 투명함을 특징으로 하는 경피 치료 시스템.
- 제1항 내지 제3항 중 어느 한 항에 있어서,활성성분 함유 저장소가 투명하고, 바람직하게는 무색 투명함을 특징으로 하는 경피 치료 시스템.
- 제1항 내지 제4항 중 어느 한 항에 있어서,전체가 투명하고, 바람직하게는 무색 투명함을 특징으로 하는 경피 치료 시스템.
- 제1항 내지 제5항 중 어느 한 항에 있어서,중합체 매트릭스는 합성 또는 부분 합성 중합체를 함유하거나 함유하지 않는 실질적으로 폴리아크릴레이트류, 폴리이소부틸렌류, 폴리메틸실록산류, 스티렌-이소프렌 블록 공중합체류, 이소프렌 중합체류로 이루어진 군에서 선택되는 중합체로 됨을 특징으로 경피 치료 시스템.
- 제1항 내지 제6항 중 어느 한 항에 있어서,UV 흡수성분(들)을 1∼20중량%, 바람직하게는 5~10중량% 함유함을 특징으로 하는 경피 치료 시스템.
- 제1항 내지 제7항 중 어느 한 항에 있어서,UV 영역에서 광을 흡수하는 성분(들)이 UV-A 및/또는 UV-B 영역에서 광을 흡수하고, 바람직하게는 250∼400nm의 파장 영역에서 광을 흡수함을 특징으로 하는 경피 치료 시스템.
- 제1항 내지 제8항 중 어느 한 항에 있어서,UV 영역에서 광을 흡수하는 성분(들)은 p-아미노벤조산 및 아미노벤조산 유도체, 바람직하게는 4-디메틸아미노벤조산-2-에틸헥실에스테르, 4-비스(폴리에톡실)아미노벤조산-폴리에톡시에틸에스테르, 신남산 및 그 유도체, 바람직하게는 4-메톡시신남산이소아밀에스테르, 4-메톡시신남산-2-에틸헥실에스테르, 3-벤질리덴-보르난-2-온 및 벤질리덴-보르난-2-온 유도체, 바람직하게는 3-(4')메틸벤질리덴-보르난-2-온, 3-(4-설포)벤질리덴-보르난-2-온, 3-(4'-트리메틸암모늄)벤질리덴-보르난-2-온-메틸설페이트, 살리실산 유도체, 바람직하게는 4-이소프로필벤질 살리실레이트, 살리실산-2-에틸헥실에스테르, 3,3,5-트리메틸-시클로헥실살리실레이트, 2,4,6-트리아닐린-p-(카보-2'-에틸-헥실-1'-옥시)1,3,5-트리아진, 3-이미다졸-4-일-아크릴산 및 그의 에스테르, 2-페닐렌벤즈이미다졸-5-설폰산 및 그의 K-, Na- 및 트리에탄올아민(=TEA)염, 2-시아노-3,3-디페닐-아크릴산, 테레프탈로일리덴-디캄포-설폰산, 부틸메톡시디벤조일메탄, 벤조페논 또는 벤조페논 유도체, 바람직하게는 벤조페논-3, 벤조페논-4로 이루어진 군에서 선택함을 특징으로 하는 경피 치료 시스템.
- 제1항 내지 제9항 중 어느 한 항에 있어서,UV 영역에서 광을 흡수하는 성분들의 흡수 최대점이 사용되는 활성성분의 분해를 일으키는 파장 영역내에 있음을 특징으로 하는 경피 치료 시스템.
- 제1항 내지 제10항 중 어느 한 항에 있어서,UV 영역에서 광을 흡수하고, 흡수 최대점이 다른 적어도 2 성분의 조합물을 함유함을 특징으로 하는 경피 치료 시스템.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10053375A DE10053375C1 (de) | 2000-10-27 | 2000-10-27 | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
DE10053375.2 | 2000-10-27 | ||
PCT/EP2001/012068 WO2002034200A2 (de) | 2000-10-27 | 2001-10-18 | Transdermale therapeutische systeme mit lichtempfindlichen wirkstoffen |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030044042A true KR20030044042A (ko) | 2003-06-02 |
KR100624502B1 KR100624502B1 (ko) | 2006-09-18 |
Family
ID=7661322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037005782A KR100624502B1 (ko) | 2000-10-27 | 2001-10-18 | 감광성 활성성분을 함유하는 경피 치료 시스템 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040022836A1 (ko) |
EP (1) | EP1328259B1 (ko) |
JP (1) | JP2004512286A (ko) |
KR (1) | KR100624502B1 (ko) |
DE (1) | DE10053375C1 (ko) |
DK (1) | DK1328259T3 (ko) |
ES (1) | ES2477997T3 (ko) |
PT (1) | PT1328259E (ko) |
WO (1) | WO2002034200A2 (ko) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004149430A (ja) * | 2002-10-29 | 2004-05-27 | Kanebo Ltd | 衛生用繊維製品およびそれを用いた衛生用品 |
EP1449526A1 (de) * | 2003-02-21 | 2004-08-25 | Schering AG | UV-stabiles transdermales Pflaster |
WO2004073696A1 (de) | 2003-02-21 | 2004-09-02 | Schering Ag | Uv-stabiles transdermales pflaster |
EP1452173A1 (de) * | 2003-02-25 | 2004-09-01 | Schering AG | UV-stabiles transdermales Pflaster |
DE10317692A1 (de) | 2003-04-17 | 2004-11-11 | Lts Lohmann Therapie-Systeme Ag | Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut |
GB0322342D0 (en) * | 2003-09-23 | 2003-10-22 | Gamble Reed | Skin patch |
US20050129756A1 (en) * | 2003-12-10 | 2005-06-16 | Hans-Peter Podhaisky | UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient |
EP1541136A1 (de) * | 2003-12-10 | 2005-06-15 | Schering AG | UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten |
US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
AU2004298930B2 (en) * | 2003-12-12 | 2009-11-26 | Bayer Intellectual Property Gmbh | Transdermal delivery system of hormones without penetration enhancers |
UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
TWI341736B (en) | 2003-12-26 | 2011-05-11 | Hisamitsu Pharmaceutical Co | Anti-infammatory adhesive preparations |
WO2006023644A2 (en) * | 2004-08-20 | 2006-03-02 | 3M Innovative Properties Company | Transdermal drug delivery device with translucent protective film |
DE102005010255A1 (de) * | 2005-03-07 | 2006-09-14 | Lts Lohmann Therapie-Systeme Ag | Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung |
US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
DE102008033343A1 (de) * | 2008-07-14 | 2010-01-21 | Beiersdorf Ag | Kosmetische Zubereitung mit neutralisierter 2-Phenylbenzimidazol-5-sulfonsäure |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
RU2573293C2 (ru) | 2010-03-26 | 2016-01-20 | Филип Моррис Продактс С.А. | Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов |
DE102010040299A1 (de) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
ES2657639T3 (es) | 2012-06-28 | 2018-03-06 | Johnson & Johnson Consumer Inc. | Composiciones de protección solar que contienen un polímero absorbente de radiación ultravioleta |
US9469725B2 (en) | 2012-06-28 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymers |
US20140004057A1 (en) | 2012-06-28 | 2014-01-02 | Johnson & Johnson Consumer Companies, Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polyester |
US9255180B2 (en) | 2012-06-28 | 2016-02-09 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polyethers |
JP6608704B2 (ja) * | 2014-01-27 | 2019-11-20 | コスメディ製薬株式会社 | コンシーラパッチ及びその製造方法、皮膚の美白ケア化粧方法並びに皮膚のにきびケア化粧方法 |
US10874603B2 (en) | 2014-05-12 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing a UV-absorbing polyglycerol and a non-UV-absorbing polyglycerol |
EP3276875B1 (en) * | 2016-07-29 | 2020-02-19 | Nxp B.V. | Method and apparatus for updating an encryption key |
US10596087B2 (en) | 2016-10-05 | 2020-03-24 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6069014A (ja) * | 1983-09-27 | 1985-04-19 | Nitto Electric Ind Co Ltd | 皮膚疾患治療用貼付剤 |
JPS60155111A (ja) * | 1983-10-20 | 1985-08-15 | Hisamitsu Pharmaceut Co Inc | 安定なケトプロフェン含有外用経皮製剤 |
US5077104A (en) * | 1989-12-21 | 1991-12-31 | Alza Corporation | Nicotine packaging materials |
JPH07204251A (ja) * | 1993-10-15 | 1995-08-08 | Dai Ichi Seiyaku Co Ltd | キノロン系抗菌薬製剤 |
US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
JPH09143077A (ja) * | 1995-11-21 | 1997-06-03 | Sumitomo Pharmaceut Co Ltd | 外用製剤 |
DE19648010A1 (de) * | 1996-11-20 | 1998-05-28 | Haarmann & Reimer Gmbh | Verwendung von substituierten Benzazolen als UV-Absorber, neue Benzazole und Verfahren zu ihrer Herstellung |
JPH10265371A (ja) | 1997-03-25 | 1998-10-06 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
JPH115962A (ja) * | 1997-04-16 | 1999-01-12 | Sekisui Chem Co Ltd | 粘着剤及び貼付剤 |
DE19753983A1 (de) * | 1997-12-05 | 1999-06-10 | Beiersdorf Ag | Verwendung von Isoquercitrin als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen sowie zur Verhinderung der polymorphen Lichtdermatose |
DE19912623A1 (de) * | 1999-03-20 | 2000-09-28 | Lohmann Therapie Syst Lts | Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile |
DE10008895A1 (de) * | 2000-02-25 | 2001-08-30 | Beiersdorf Ag | Stabilisierung oxidations- und/oder UV-empfindlicher Wirkstoffe |
DE10010814A1 (de) * | 2000-03-08 | 2001-09-13 | Basf Ag | Verwendung von 4-Oxoretinol und dessen Derivaten in kosmetischen Zubereitungen |
-
2000
- 2000-10-27 DE DE10053375A patent/DE10053375C1/de not_active Expired - Lifetime
-
2001
- 2001-10-18 JP JP2002537254A patent/JP2004512286A/ja active Pending
- 2001-10-18 WO PCT/EP2001/012068 patent/WO2002034200A2/de active Application Filing
- 2001-10-18 EP EP01988570.6A patent/EP1328259B1/de not_active Expired - Lifetime
- 2001-10-18 US US10/415,144 patent/US20040022836A1/en not_active Abandoned
- 2001-10-18 KR KR1020037005782A patent/KR100624502B1/ko active IP Right Grant
- 2001-10-18 DK DK01988570.6T patent/DK1328259T3/da active
- 2001-10-18 PT PT1988570T patent/PT1328259E/pt unknown
- 2001-10-18 ES ES01988570.6T patent/ES2477997T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1328259B1 (de) | 2014-04-09 |
DE10053375C1 (de) | 2002-01-24 |
WO2002034200A3 (de) | 2003-01-30 |
US20040022836A1 (en) | 2004-02-05 |
JP2004512286A (ja) | 2004-04-22 |
EP1328259A2 (de) | 2003-07-23 |
KR100624502B1 (ko) | 2006-09-18 |
DK1328259T3 (da) | 2014-06-10 |
ES2477997T3 (es) | 2014-07-18 |
WO2002034200A2 (de) | 2002-05-02 |
PT1328259E (pt) | 2014-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100624502B1 (ko) | 감광성 활성성분을 함유하는 경피 치료 시스템 | |
US9095691B2 (en) | UV stable transdermal therapeutic plaster with a UV absorbing self-adhesive layer separated from the drug matrix | |
US8962013B2 (en) | Multi-layered transdermal system with triazine UV absorber | |
US9205059B2 (en) | Transparent transdermal nicotine delivery devices | |
US20050129756A1 (en) | UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient | |
HU227814B1 (en) | Transdermal device containing polyvinylpyrrolidone as solubility enhancer | |
HU220861B1 (en) | Active-substance patch for releasing estradiol to the skin | |
WO1997020582A3 (en) | Transdermal patch for comparative evaluations | |
CA2605112C (en) | Solid transdermal therapeutic system comprising uv absorber | |
JP2002539238A (ja) | 感光性治療システムまたはその成分の貯蔵時および/または使用時における安定性向上方法 | |
CN100562310C (zh) | Uv稳定的透皮硬膏剂 | |
CA2410336A1 (en) | Transdermal therapeutical system with a reduced tendency of the active substance to crystallize |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120903 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130830 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140901 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150828 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160829 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170901 Year of fee payment: 12 |